NO20031694D0 - Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament - Google Patents

Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament

Info

Publication number
NO20031694D0
NO20031694D0 NO20031694A NO20031694A NO20031694D0 NO 20031694 D0 NO20031694 D0 NO 20031694D0 NO 20031694 A NO20031694 A NO 20031694A NO 20031694 A NO20031694 A NO 20031694A NO 20031694 D0 NO20031694 D0 NO 20031694D0
Authority
NO
Norway
Prior art keywords
preparation
drug
manufacture
crystalline monohydrate
bromide
Prior art date
Application number
NO20031694A
Other languages
English (en)
Other versions
NO328465B1 (no
NO20031694L (no
Inventor
Rolf Banholzer
Manfred Graulich
Christian Kulinna
Andreas Mathes
Helmut Meissner
Peter Sieger
Peter Specht
Michael Trunk
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031694(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20031694D0 publication Critical patent/NO20031694D0/no
Publication of NO20031694L publication Critical patent/NO20031694L/no
Publication of NO328465B1 publication Critical patent/NO328465B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20031694A 2000-10-12 2003-04-11 Krystallinsk monohydrat, fremgangsmate for fremstilling derav og anvendelse derav til fremstilling av et medikament NO328465B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050621 2000-10-12
PCT/EP2001/011225 WO2002030928A1 (de) 2000-10-12 2001-09-28 Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (3)

Publication Number Publication Date
NO20031694D0 true NO20031694D0 (no) 2003-04-11
NO20031694L NO20031694L (no) 2003-04-11
NO328465B1 NO328465B1 (no) 2010-02-22

Family

ID=7659568

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031694A NO328465B1 (no) 2000-10-12 2003-04-11 Krystallinsk monohydrat, fremgangsmate for fremstilling derav og anvendelse derav til fremstilling av et medikament

Country Status (47)

Country Link
EP (2) EP1468998A1 (no)
JP (1) JP3764422B2 (no)
KR (1) KR100823860B1 (no)
CN (2) CN1221549C (no)
AP (1) AP1572A (no)
AR (2) AR034389A1 (no)
AT (1) ATE276253T1 (no)
AU (2) AU1499602A (no)
BG (1) BG66161B1 (no)
BR (1) BR0114584A (no)
CA (1) CA2425539C (no)
CR (1) CR6938A (no)
CZ (1) CZ301841B6 (no)
DE (1) DE50103666D1 (no)
DK (1) DK1326862T3 (no)
DZ (1) DZ3478A1 (no)
EA (1) EA004381B1 (no)
EC (1) ECSP034540A (no)
EE (1) EE04567B1 (no)
EG (1) EG24142A (no)
ES (1) ES2228965T3 (no)
GE (1) GEP20063905B (no)
HK (2) HK1060567A1 (no)
HR (1) HRP20030276B1 (no)
HU (1) HU226830B1 (no)
IL (2) IL155335A0 (no)
IS (1) IS2339B (no)
MA (1) MA25842A1 (no)
ME (2) MEP40008A (no)
MX (1) MXPA03003221A (no)
MY (1) MY126931A (no)
NO (1) NO328465B1 (no)
NZ (1) NZ525733A (no)
OA (1) OA12403A (no)
PE (1) PE20020422A1 (no)
PL (1) PL207870B1 (no)
PT (1) PT1326862E (no)
RS (1) RS50218B (no)
SA (1) SA01220412B1 (no)
SI (1) SI1326862T1 (no)
SK (1) SK287009B6 (no)
TR (1) TR200402579T4 (no)
TW (1) TW589313B (no)
UA (1) UA74215C2 (no)
UY (2) UY26962A1 (no)
WO (1) WO2002030928A1 (no)
ZA (1) ZA200302500B (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
BR0210537A (pt) * 2001-06-22 2004-06-22 Boehringer Ingelheim Pharma Anticolinérgico cristalino, processo para a sua preparação e sua aplicação para a preparação de um medicamento
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US7968717B2 (en) 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
RS20060291A (en) * 2003-11-03 2008-06-05 Boehringer Ingelheim International Gmbh., Novel crystalline anhydride with anticholinergic effect
UY28589A1 (es) * 2003-11-03 2005-06-30 Boehringer Ingelheim Int Nuevas sales de tiotropio, procedimientos para su preparación , así como formulaciones medicamentosas que las contienen
PT1682541E (pt) 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
KR101287460B1 (ko) 2004-04-22 2013-07-23 베링거 인겔하임 인터내셔날 게엠베하 벤즈옥사진을 함유하는 호흡기 질환 치료용 약제학적배합물
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ES2322148T3 (es) 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
MX2007004768A (es) * 2004-10-21 2007-05-10 Boehringer Ingelheim Int Blister para inhaladores.
EP1858554A2 (en) * 2005-03-09 2007-11-28 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
DE102005019201A1 (de) 2006-04-19 2006-11-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Verbindungen zur Behandlung von entzündlichen Erkrankungen
JP5053997B2 (ja) 2005-04-28 2012-10-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 炎症性疾患の治療用の新規化合物
ES2393794T3 (es) 2005-05-02 2012-12-28 Boehringer Ingelheim International Gmbh Nuevas formas cristalinas de bromuro de tiotropio
CN101203513A (zh) * 2005-05-02 2008-06-18 贝林格尔·英格海姆国际有限公司 噻托溴铵的晶型
NZ583872A (en) * 2005-06-15 2011-10-28 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
JP2009504604A (ja) * 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 重症持続型喘息の治療におけるチオトロピウム塩の使用
MX2008001976A (es) 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
US20070086957A1 (en) 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
MX2007009987A (es) * 2005-12-19 2007-10-02 Sicor Inc Bromuro de tiotropio puro y estable.
US8163913B2 (en) * 2005-12-19 2012-04-24 Sicor Inc. Forms of tiotropium bromide and processes for preparation thereof
CN101355937A (zh) * 2006-01-04 2009-01-28 贝林格尔·英格海姆国际有限公司 噻托铵盐在治疗中度持续性哮喘中的用途
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
ATE505193T1 (de) 2006-08-07 2011-04-15 Boehringer Ingelheim Int Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
PE20080610A1 (es) 2006-08-22 2008-07-15 Boehringer Ingelheim Int Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
EP1923393A1 (en) * 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
CA2705414C (en) 2007-10-19 2016-05-24 Boehringer Ingelheim International Gmbh Substituted piperidino-dihydrothienopyrimidines
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
WO2010011813A1 (en) * 2008-07-23 2010-01-28 Alkermes, Inc. Complex of trospium and pharmaceutical compositions thereof
EA020548B1 (ru) 2008-12-19 2014-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Циклические пиримидин-4-карбоксамиды в качестве антагонистов рецептора ccr2, предназначенные для лечения воспаления, астмы и хозл
EP2201934A1 (en) 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
EP2403851B1 (en) 2009-03-06 2015-06-17 Mahmut Bilgic New crystalline forms of tiotropium bromide
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
CA2931876A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Anhydrate of tiotropium bromide
JP5658272B2 (ja) 2009-12-17 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２の新規アンタゴニスト及びこれらの使用
NZ599770A (en) 2009-12-17 2014-06-27 Boehringer Ingelheim Int New ccr2 receptor antagonists and uses thereof
WO2011092128A1 (en) 2010-01-29 2011-08-04 Boehringer Ingelheim International Gmbh Substituted naphthyridines and their use as syk kinase inhibitors
WO2011141477A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011141474A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
US8841313B2 (en) 2010-05-17 2014-09-23 Boehringer Ingelheim International Gmbh CCR2 antagonists and uses thereof
WO2011147772A1 (en) 2010-05-25 2011-12-01 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists
US8962656B2 (en) 2010-06-01 2015-02-24 Boehringer Ingelheim International Gmbh CCR2 antagonists
EP2668177B1 (en) 2011-01-28 2014-10-22 Boehringer Ingelheim International GmbH Substituted pyridinyl-pyrimidines and their use as medicaments
TR201102068A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
JP5786257B2 (ja) 2011-06-16 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の選択的ｃｃｒ２拮抗薬
JP5786258B2 (ja) 2011-07-15 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規かつ選択的なｃｃｒ２拮抗薬
CA2843022C (en) 2011-07-26 2019-09-24 Boehringer Ingelheim International Gmbh Substituted quinolines and their use as medicaments
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) * 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
EP2914593B1 (en) 2012-11-05 2017-01-11 Zentiva, k.s. Stabilization of tiotropium solvates
EP2913332A1 (en) * 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
PT3119772T (pt) 2014-03-19 2019-09-05 Boehringer Ingelheim Int Inibidores de syk heteroarilo
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
RU2567539C1 (ru) * 2015-02-04 2015-11-10 Индивидуальный предприниматель Михайлов Олег Ростиславович КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
WO2018084817A2 (en) * 2016-11-04 2018-05-11 Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇ A new form of active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
KR100312357B1 (ko) * 1992-12-09 2002-04-24 데이비드 이. 프랭크하우저 안정화된약제의에어로졸용액제제
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
US6475467B1 (en) * 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations

Also Published As

Publication number Publication date
CA2425539A1 (en) 2003-04-11
CN1733761A (zh) 2006-02-15
EG24142A (en) 2008-08-06
MEP40008A (en) 2011-02-10
UA74215C2 (uk) 2005-11-15
IL155335A (en) 2009-02-11
ZA200302500B (en) 2004-04-22
JP3764422B2 (ja) 2006-04-05
MY126931A (en) 2006-10-31
EP1468998A1 (de) 2004-10-20
MXPA03003221A (es) 2004-12-03
BR0114584A (pt) 2003-08-26
CN1221549C (zh) 2005-10-05
EE200300171A (et) 2003-06-16
AU2002214996B2 (en) 2007-03-15
BG107687A (bg) 2003-09-30
SK4362003A3 (en) 2003-08-05
HRP20030276B1 (en) 2006-02-28
HUP0301022A2 (hu) 2003-10-28
KR20030042008A (ko) 2003-05-27
ME00243B (me) 2011-05-10
EA004381B1 (ru) 2004-04-29
CR6938A (es) 2004-10-28
NO328465B1 (no) 2010-02-22
CN100519558C (zh) 2009-07-29
MA25842A1 (fr) 2003-07-01
KR100823860B1 (ko) 2008-04-21
SA01220412B1 (ar) 2006-11-05
BG66161B1 (bg) 2011-09-30
CA2425539C (en) 2007-04-03
CZ301841B6 (cs) 2010-07-07
DZ3478A1 (fr) 2002-04-18
EP1326862B1 (de) 2004-09-15
AP1572A (en) 2006-02-13
JP2004526668A (ja) 2004-09-02
ES2228965T3 (es) 2005-04-16
HU226830B1 (en) 2009-11-30
PE20020422A1 (es) 2002-06-28
NO20031694L (no) 2003-04-11
ECSP034540A (es) 2003-07-25
HRP20030276A2 (en) 2005-02-28
AR034389A1 (es) 2004-02-25
IS2339B (is) 2008-02-15
NZ525733A (en) 2005-01-28
PL207870B1 (pl) 2011-02-28
ATE276253T1 (de) 2004-10-15
HUP0301022A3 (en) 2005-12-28
PL366041A1 (en) 2005-01-24
WO2002030928A1 (de) 2002-04-18
OA12403A (en) 2006-04-18
DK1326862T3 (da) 2004-11-22
TR200402579T4 (tr) 2004-12-21
HK1060567A1 (en) 2004-08-13
EA200300457A1 (ru) 2003-10-30
SK287009B6 (sk) 2009-09-07
EP1326862A1 (de) 2003-07-16
UY34901A (es) 2015-02-27
SI1326862T1 (en) 2005-02-28
DE50103666D1 (de) 2004-10-21
CN1469877A (zh) 2004-01-21
YU27303A (sh) 2006-05-25
PT1326862E (pt) 2004-11-30
TW589313B (en) 2004-06-01
AR068527A2 (es) 2009-11-18
IL155335A0 (en) 2003-11-23
IS6772A (is) 2003-04-09
EE04567B1 (et) 2005-12-15
AP2003002775A0 (en) 2003-03-31
AU1499602A (en) 2002-04-22
HK1086557A1 (en) 2006-09-22
UY26962A1 (es) 2002-06-20
GEP20063905B (en) 2006-08-25
RS50218B (sr) 2009-07-15

Similar Documents

Publication Publication Date Title
NO20031694D0 (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
ATE284388T1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
HUP0400333A2 (hu) Kristályos antikolinergikum, eljárás előállítására és alkalmazása gyógyszerkészítmény előállítására
DE60132975D1 (de) Neue substanzen und verbindungen als protease-inhibitoren
DK1385519T3 (da) Tiotropiumsalte til behandling af inflammatoriske sygdomme
RS57551B1 (sr) Mikronizovani kristalni tiotropium bromid
UY27138A1 (es) Composiciones farmacéuticas, formas de dosificación y métodos para la administración oral de epotilonas.
MXPA03001431A (es) Polimeros de un analogo de epotilona.
NO20051692L (no) Anvendelse av indolylderivater for fremstilling av et medikament for behandling av allergisk rhinitt
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
AR034223A1 (es) Novedosa indicacion terapeutica de azitromicina para el tratamiento de enfermedades inflamatorias no infecciosas
NO20025394D0 (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
UY28457A1 (es) Nueva composición
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
ATE343576T1 (de) 7-azaindolderivate als cox2-inhibitoren
EE200200605A (et) Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
EA200400382A1 (ru) Применение специфической дозы фондапаринукса натрия для лечения окс
NO20014889L (no) Fremgangsmåte for fremstilling av medisinske midler
RU2000114403A (ru) Способ лечения язвенной болезни луковицы двенадцатиперстной кишки, осложненной стенозом
UA3713U (uk) Спосіб корекції порушень імунологічного статусу у дітей

Legal Events

Date Code Title Description
MK1K Patent expired